Drugmakers’ financial fortunes during Covid-19 may hinge on their product mix

Analyst reports over the past few weeks have looked into what effects the Covid-19 pandemic could have on drugmakers' sales, examining multiple factors. But virtual launches and telemedicine could mitigate some market challenges.